Anthem Biosciences Ltd Technical Momentum Shifts Amid Mixed Signals

Current Price and Recent Performance

As of 5 August 2026, Anthem Biosciences is trading at ₹818.60, down from the previous close of ₹830.50. The stock’s intraday range has been relatively tight, with a low of ₹809.95 and a high of ₹846.45. Over the past 52 weeks, the share price has fluctuated between ₹579.45 and ₹873.25, indicating a significant recovery from its lows but still shy of its peak.

Technical Trend Overview

The company’s technical trend has softened from a strong bullish posture to a mildly bullish one. This subtle shift is reflected in several key indicators. The Moving Averages on the daily chart remain bullish, signalling that the short-term momentum is still positive. However, the weekly KST (Know Sure Thing) indicator has turned mildly bearish, suggesting some caution in the medium term.

Meanwhile, the MACD (Moving Average Convergence Divergence) on the weekly timeframe remains bullish, supporting the notion of underlying strength. The monthly MACD, however, does not currently provide a clear directional signal, indicating a potential consolidation phase or indecision among longer-term investors.

RSI and Bollinger Bands Analysis

The Relative Strength Index (RSI) on the weekly and monthly charts is neutral, offering no definitive buy or sell signals. This neutrality suggests that the stock is neither overbought nor oversold, which could imply a period of sideways movement or a pause before the next directional move.

Conversely, the Bollinger Bands on the weekly chart remain bullish, indicating that price volatility is contained within an upward trending channel. This technical setup often precedes a continuation of the prevailing trend, provided no external shocks disrupt the momentum.

Volume and Dow Theory Signals

On-Balance Volume (OBV) on the weekly chart is mildly bearish, signalling that volume trends are not fully supporting the recent price action. This divergence between price and volume can be a warning sign of weakening conviction among buyers.

Dow Theory assessments on both weekly and monthly timeframes are mildly bullish, reinforcing the view that the broader trend remains positive but with some reservations. This aligns with the overall technical narrative of a stock in transition rather than a decisive breakout or breakdown.

Comparative Returns and Market Context

Anthem Biosciences has outperformed the Sensex significantly over multiple time horizons. Year-to-date, the stock has delivered a robust return of 25.74%, compared to the Sensex’s negative 7.97%. Over the past month, the stock gained 6.35%, while the Sensex rose a modest 0.86%. Even on a one-week basis, Anthem’s 4.41% return eclipsed the Sensex’s 2.17% gain.

However, over the one-year period, the stock’s return of 8.71% contrasts with the Sensex’s decline of 3.20%, indicating resilience amid broader market weakness. Longer-term data for three, five, and ten years is not available for Anthem, but the Sensex’s strong cumulative gains over these periods (19.34%, 44.25%, and 182.99% respectively) set a high benchmark for the company’s future performance.

Mojo Score and Rating Revision

MarketsMOJO currently assigns Anthem Biosciences a Mojo Score of 57.0, categorising it as a ‘Hold’ with a mid-cap market cap grade. This represents a downgrade from a previous ‘Buy’ rating issued on 21 May 2026. The revision reflects the tempered technical momentum and mixed signals from key indicators, suggesting investors should exercise caution and monitor developments closely.

Technical Indicator Summary

To summarise the technical landscape:

• MACD Weekly: Bullish
• MACD Monthly: No clear signal
• RSI Weekly & Monthly: Neutral
• Bollinger Bands Weekly: Bullish
• Moving Averages Daily: Bullish
• KST Weekly: Mildly Bearish
• Dow Theory Weekly & Monthly: Mildly Bullish
• OBV Weekly: Mildly Bearish

These mixed signals indicate that while short-term momentum remains positive, medium-term caution is warranted. The divergence between price strength and volume trends, alongside neutral RSI readings, suggests the stock may be consolidating before its next significant move.

Investor Takeaway

For investors, Anthem Biosciences presents a nuanced technical picture. The stock’s strong relative returns versus the Sensex and bullish daily moving averages suggest underlying strength. However, the downgrade in Mojo Grade from ‘Buy’ to ‘Hold’ and the mixed medium-term technical signals counsel prudence.

Those considering new positions should watch for confirmation of trend direction, particularly through volume trends and momentum indicators like the KST and MACD on monthly charts. Existing holders may wish to monitor support levels near recent lows and be alert to any shifts in RSI or Bollinger Band behaviour that could signal renewed momentum or a potential correction.

Overall, Anthem Biosciences remains a stock with potential, but one that requires careful technical analysis and risk management in the current market environment.

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →